Translational Research: From Mechanisms of Influenza Transmission to Prevention
转化研究:从流感传播机制到预防
基本信息
- 批准号:7936218
- 负责人:
- 金额:$ 51.72万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-09-26 至 2012-08-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAerosolsAntiviral AgentsAreaAsthmaAvian InfluenzaBasic ScienceBiologicalBiological AssayBirdsBreathingCenters for Disease Control and Prevention (U.S.)CharacteristicsClassificationCollectionComputer SimulationCoughingDataDiabetes MellitusDrug resistanceEffectivenessEquipmentFundingGeneral PopulationGenesHandwashingHealth PersonnelHospitalsHumanInfectionInfection ControlInfluenzaInstitute of Medicine (U.S.)Integration Host FactorsInterventionIntervention TrialKnowledgeLegal patentMasksMeasuresMechanical VentilatorsModelingMolecularNoseOperative Surgical ProceduresOseltamivirParticipantPatientsPersonsPharmacologic SubstancePhasePlant RootsPreventionPublic HealthReadinessRecommendationRelative (related person)ReportingResistanceRoleSample SizeSeasonsSocial DistanceSourceSpecimenSwabSystemTestingTimeTranslatingTranslational ResearchUniversitiesUse EffectivenessVaccinesVirusVirus Sheddingbasedesigneffectiveness researchfluflu transmissionimprovedinfluenzavirusnew technologypandemic diseasepandemic influenzaparticlepathogenpublic health relevanceresearch studyresidenceresistance mechanismrespiratoryrespiratory virusseasonal influenzatranslational approachtransmission process
项目摘要
DESCRIPTION (provided by applicant): This application addresses broad Challenge Area (15) Translational Research and specific Challenge Topic, 151-AI-106: Translational research focused on high priority pathogens (influenza) and basic research focused on resistance mechanisms. Pandemic influenza remains an important threat - we are currently under a Phase 3 Alert of the WHO Global Influenza Preparedness Plan. During this phase, one of our essential tasks is to test and optimize public health intervention strategies to reduce transmission of influenza. Key among these strategies is social distancing and use of personal protective equipment including surgical masks. Unfortunately, traditional effectiveness research using empirical tests of these approaches has been mostly uninformative because of limited compliance with mask use and a requirement for very large sample sizes. Thus, we need a translational approach, rooted in basic science about how influenza is transmitted, to design and test interventions. An Institute of Medicine report, however, recently pointed out that basic data on how influenza is transmitted is lacking, posing a critical knowledge gap. Therefore, we propose to address that critical basic knowledge gap, test a specific intervention strategy, and to translate our findings into public health recommendations. We propose to use a new technology that we recently developed for biological particle collection (U.S. Provisional Patent Application No. 61/162,395) to make fundamental observations on infectious respiratory droplets in a study of 220 naturally occurring seasonal influenza cases over two influenza seasons. We will collect respiratory droplets shed by participants while breathing normally, talking, and spontaneously coughing. We will characterize the size distribution of droplets containing infectious virus and observe the impact of host factors (e.g. asthma), virus type and strain, and drug resistance on virus shedding into respiratory droplets. We will also test the effectiveness of surgical masks to limit the release of infectious droplets and whether this effect is dependent on type, strain, drug resistance, and host characteristics. We will use these basic data to examine the roles of large and small respiratory droplets and examine how the interaction of host factors and virus type impact the shedding of infectious respiratory droplets. These data will also provide a baseline for comparison to determine whether experimental human infections accurately mimic the viral shedding of people with naturally acquired, wild-type infections. Without this basic data, it will not be possible to know whether large experimental studies of influenza transmission adequately represent likely modes of transmission in the real world. Thus, this project will improve our understanding of the mechanisms of transmission for seasonal influenza; the effect of type, strain, co-infection, and drug resistance on virus release in large and small respiratory droplets; and provide evidence necessary to translate knowledge of transmission mechanisms into infection control recommendations for hospitals and the general public.
PUBLIC HEALTH RELEVANCE: This project will address a critical knowledge gap about how influenza is transmitted. It will provide guidance on what public health measures are likely to be effective for limiting transmission during an influenza pandemic. The project will evaluate whether surgical masks can limit release of infectious virus from influenza patients, and provide a basis for determining when and if respirators capable of capturing fine particle aerosols are needed to protect health care workers treating influenza patients.
描述(由申请人提供):本申请涉及广泛的挑战领域(15)转化研究和特定的挑战主题,151-AI-106:转化研究侧重于高优先级病原体(流感)和基础研究侧重于耐药机制。大流行性流感仍然是一个重要的威胁-我们目前处于世卫组织全球流感防备计划的第3级警报之下。在这一阶段,我们的一项重要任务是测试和优化公共卫生干预战略,以减少流感的传播。这些策略中的关键是保持社交距离和使用包括外科口罩在内的个人防护设备。不幸的是,传统的有效性研究,使用这些方法的经验性测试,大多是没有信息的,因为有限的遵守口罩的使用和非常大的样本量的要求。因此,我们需要一种转化方法,植根于关于流感如何传播的基础科学,以设计和测试干预措施。然而,医学研究所最近的一份报告指出,缺乏关于流感如何传播的基本数据,这构成了一个关键的知识缺口。因此,我们建议解决这一关键的基本知识差距,测试具体的干预策略,并将我们的研究结果转化为公共卫生建议。我们建议使用我们最近开发的用于生物颗粒收集的新技术(美国临时专利申请No. 61/162,395),以在两个流感季节的220个自然发生的季节性流感病例的研究中对感染性呼吸道飞沫进行基本观察。我们将收集参与者在正常呼吸、说话和自发咳嗽时流下的呼吸道飞沫。我们将描述含有传染性病毒的飞沫的大小分布,并观察宿主因素(如哮喘)、病毒类型和毒株以及耐药性对病毒脱落到呼吸道飞沫中的影响。我们还将测试外科口罩限制传染性飞沫释放的有效性,以及这种效果是否取决于类型、菌株、耐药性和宿主特征。我们将使用这些基本数据来研究大小呼吸道飞沫的作用,并研究宿主因素和病毒类型的相互作用如何影响感染性呼吸道飞沫的脱落。这些数据还将提供比较的基线,以确定实验性人类感染是否准确模拟自然获得的野生型感染者的病毒脱落。没有这些基本数据,就不可能知道流感传播的大型实验研究是否充分代表了真实的世界中可能的传播模式。因此,该项目将提高我们对季节性流感传播机制的理解;类型,菌株,合并感染和耐药性对大小呼吸道飞沫中病毒释放的影响;并提供必要的证据,将传播机制的知识转化为医院和公众的感染控制建议。
公共卫生相关性:该项目将解决有关流感如何传播的关键知识缺口。它将为在流感大流行期间采取哪些公共卫生措施可能有效限制传播提供指导。该项目将评估外科口罩是否可以限制流感患者释放传染性病毒,并为确定何时以及是否需要能够捕获细颗粒气溶胶的净化器来保护治疗流感患者的医护人员提供依据。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Infectious virus in exhaled breath of symptomatic seasonal influenza cases from a college community.
- DOI:10.1073/pnas.1716561115
- 发表时间:2018-01-30
- 期刊:
- 影响因子:11.1
- 作者:Yan J;Grantham M;Pantelic J;Bueno de Mesquita PJ;Albert B;Liu F;Ehrman S;Milton DK;EMIT Consortium
- 通讯作者:EMIT Consortium
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Donald Kirby Milton其他文献
Donald Kirby Milton的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Donald Kirby Milton', 18)}}的其他基金
Evaluating Modes of Influenza Transmission using a Randomized Controlled Trial (EMIT-2-RCT)
使用随机对照试验 (EMIT-2-RCT) 评估流感传播模式
- 批准号:
10471987 - 财政年份:2021
- 资助金额:
$ 51.72万 - 项目类别:
Evaluating Modes of Influenza Transmission (EMIT-2) using Innovative Technologies and Designs in Controlled Environments
在受控环境中使用创新技术和设计评估流感传播模式 (EMIT-2)
- 批准号:
10471978 - 财政年份:2021
- 资助金额:
$ 51.72万 - 项目类别:
Evaluating Modes of Influenza Transmission using a Randomized Controlled Trial (EMIT-2-RCT)
使用随机对照试验 (EMIT-2-RCT) 评估流感传播模式
- 批准号:
10260849 - 财政年份:2021
- 资助金额:
$ 51.72万 - 项目类别:
Evaluating Modes of Influenza Transmission (EMIT-2) using Innovative Technologies and Designs in Controlled Environments
在受控环境中使用创新技术和设计评估流感传播模式 (EMIT-2)
- 批准号:
10260845 - 财政年份:2021
- 资助金额:
$ 51.72万 - 项目类别:
Evaluating Modes of Influenza Transmission (EMIT-2) using Innovative Technologies and Designs in Controlled Environments
在受控环境中使用创新技术和设计评估流感传播模式 (EMIT-2)
- 批准号:
10645155 - 财政年份:2021
- 资助金额:
$ 51.72万 - 项目类别:
Evaluating Modes of Influenza Transmission using a Randomized Controlled Trial (EMIT-2-RCT)
使用随机对照试验 (EMIT-2-RCT) 评估流感传播模式
- 批准号:
10645167 - 财政年份:2021
- 资助金额:
$ 51.72万 - 项目类别:
Translational Research: From Mechanisms of Influenza Transmission to Prevention
转化研究:从流感传播机制到预防
- 批准号:
7988354 - 财政年份:2009
- 资助金额:
$ 51.72万 - 项目类别:
相似海外基金
AEROSOLS - AIR QUALITY AND HEALTH IMPACT OF PRIMARY SEMI-VOLATILE AND SECONDARY PARTICLES AND THEIR ABATEMENT
气溶胶 - 一次半挥发性颗粒和二次颗粒对空气质量和健康的影响及其消除
- 批准号:
10092043 - 财政年份:2024
- 资助金额:
$ 51.72万 - 项目类别:
EU-Funded
Molecular-level Understanding Of Atmospheric Aerosols (MUOAA 2024); Corsica, France; April 1-5, 2024
对大气气溶胶的分子水平理解(MUOAA 2024);
- 批准号:
2332007 - 财政年份:2024
- 资助金额:
$ 51.72万 - 项目类别:
Standard Grant
TWISTA (The Wide-ranging Impacts of STratospheric smoke Aerosols)
TWISTA(平流层烟雾气溶胶的广泛影响)
- 批准号:
NE/Y000021/1 - 财政年份:2024
- 资助金额:
$ 51.72万 - 项目类别:
Research Grant
TWISTA (The Wide-ranging Impacts of STratospheric smoke Aerosols)
TWISTA(平流层烟雾气溶胶的广泛影响)
- 批准号:
NE/Y000358/1 - 财政年份:2024
- 资助金额:
$ 51.72万 - 项目类别:
Research Grant
Southern Ocean aerosols: sources, sinks and impact on cloud properties
南大洋气溶胶:来源、汇以及对云特性的影响
- 批准号:
DP240100389 - 财政年份:2024
- 资助金额:
$ 51.72万 - 项目类别:
Discovery Projects
An AI-driven clinical washbasin unit that automatically disinfects pathogens, reduces aerosols and decreases healthcare-acquired infections by 70%
%20人工智能驱动%20临床%20洗脸盆%20单位%20%20自动%20消毒%20病原体,%20减少%20气溶胶%20和%20减少%20医疗保健获得性%20感染%20by%2070%
- 批准号:
83001507 - 财政年份:2023
- 资助金额:
$ 51.72万 - 项目类别:
Innovation Loans
Cloudbusting with JWST: characterising aerosols, aurorae and chemistry in substellar atmospheresto the water cloud regime
使用 JWST 进行云消除:描述水云状态下恒星大气中的气溶胶、极光和化学成分
- 批准号:
ST/X001091/1 - 财政年份:2023
- 资助金额:
$ 51.72万 - 项目类别:
Research Grant
INvestigating Home water and Aerosols' Links to opportunistic pathogen Exposure (INHALE): do consumer decisions impact pathogen exposure and virulence?
调查家庭用水和气溶胶与机会性病原体暴露(吸入)的联系:消费者的决定是否会影响病原体暴露和毒力?
- 批准号:
2326096 - 财政年份:2023
- 资助金额:
$ 51.72万 - 项目类别:
Standard Grant
Bioactivated Aerosols for Combustion Product Capture
用于燃烧产物捕获的生物活性气溶胶
- 批准号:
10080253 - 财政年份:2023
- 资助金额:
$ 51.72万 - 项目类别:
Small Business Research Initiative